---
figid: PMC5339794__srep44015-f3
figtitle: 'Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate
  in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis'
organisms:
- Homo sapiens
- Bathymaster signatus
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC5339794
filename: srep44015-f3.jpg
figlink: /pmc/articles/PMC5339794/figure/f3/
number: F3
caption: 'Schematic representation of the intracellular folate biosynthetic pathway
  and the gene polymorphisms detected in previous studies (in green), the polymorphisms
  included in the present meta-analysis were highlighted in red or blue, and the SNPs
  in red showed associations with the MTX effectiveness in RA patients. MTX: Methotrexate;
  MTX-PGs: Methotrexate polyglutamates; Transport system: SLC16A7, SLC19A1, SLC46A1
  and SLC22A11: Solute carriers; SLCO 1B1: Solute carrier organic anion transporter;
  RFC-1: Reduced folate carrier 1; ABCC1–4, ABCB1 and ABCG2: Adenosine triphosphate–binding
  cassette (ABC) transporters. Enzymes: ADA: Adenosine deaminase; ATIC: -Aminoimidazole-4-carboxamide
  ribonucleotide transformylase/IMP cyclohydrolase; IMP: Inosine monophosphate; IMPDH2:
  Inosine 5′-monophosphate dehydrogenase; CBS: Cystathionine-β-synthase; CL: Cystathionine
  lyase; DHFR: Dihydrofolate reductase; FPGS: Folylpolyglutamyl synthase; GGH: Glutamyl
  hydrolase; CCND1: Cyclin D1; MS: Methionine synthase; MTHFR: Methylenetetrahydrofolate
  reductase; MTHFD1: Methylenetetrahydrofolate dehydrogenase; MTRR: Methionine synthase
  reductase; SHMT: Serine hydroxymethyltransferase; TYMS: thymidylate; TSER: Thymidylate
  synthase enhancer region. Metabolites: ADP: Adenosine diphosphate; AICAR: 5-aminoimidazole-4-carboxamide
  ribonucleotide; AMP: Adenosine monophosphate; ATP: Adenosine triphosphate; CH3:
  Methyl group; DHF: Dihydrofolate; dTMP: Deoxythymidine-5′-monophosphate; dUMP: Deoxyuridine-5′-monophosphate;
  FAICAR: 10-formyl-AICAR; ITP: Inosine triphosphate; ITPA: Inosine triphosphate pyrophosphatase;
  THF: tetrahydrofolate. Disease associated gene polymorphisms: ESR: Estrogen receptors;
  AIF-1: Allograft inflammatory factor-1; PTPN2: Protein tyrosine phosphatase non-receptor
  type 22; HLA: Human leukocyte antigen; TLR4: Toll-like receptor 4; CXC: Chemokines;
  TGFB: tissue growth factor β.'
papertitle: 'Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate
  in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.'
reftext: Qi Qiu, et al. Sci Rep. 2017;7:44015.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9401728
figid_alias: PMC5339794__F3
figtype: Figure
redirect_from: /figures/PMC5339794__F3
ndex: 52350c45-df05-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5339794__srep44015-f3.html
  '@type': Dataset
  description: 'Schematic representation of the intracellular folate biosynthetic
    pathway and the gene polymorphisms detected in previous studies (in green), the
    polymorphisms included in the present meta-analysis were highlighted in red or
    blue, and the SNPs in red showed associations with the MTX effectiveness in RA
    patients. MTX: Methotrexate; MTX-PGs: Methotrexate polyglutamates; Transport system:
    SLC16A7, SLC19A1, SLC46A1 and SLC22A11: Solute carriers; SLCO 1B1: Solute carrier
    organic anion transporter; RFC-1: Reduced folate carrier 1; ABCC1–4, ABCB1 and
    ABCG2: Adenosine triphosphate–binding cassette (ABC) transporters. Enzymes: ADA:
    Adenosine deaminase; ATIC: -Aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP
    cyclohydrolase; IMP: Inosine monophosphate; IMPDH2: Inosine 5′-monophosphate dehydrogenase;
    CBS: Cystathionine-β-synthase; CL: Cystathionine lyase; DHFR: Dihydrofolate reductase;
    FPGS: Folylpolyglutamyl synthase; GGH: Glutamyl hydrolase; CCND1: Cyclin D1; MS:
    Methionine synthase; MTHFR: Methylenetetrahydrofolate reductase; MTHFD1: Methylenetetrahydrofolate
    dehydrogenase; MTRR: Methionine synthase reductase; SHMT: Serine hydroxymethyltransferase;
    TYMS: thymidylate; TSER: Thymidylate synthase enhancer region. Metabolites: ADP:
    Adenosine diphosphate; AICAR: 5-aminoimidazole-4-carboxamide ribonucleotide; AMP:
    Adenosine monophosphate; ATP: Adenosine triphosphate; CH3: Methyl group; DHF:
    Dihydrofolate; dTMP: Deoxythymidine-5′-monophosphate; dUMP: Deoxyuridine-5′-monophosphate;
    FAICAR: 10-formyl-AICAR; ITP: Inosine triphosphate; ITPA: Inosine triphosphate
    pyrophosphatase; THF: tetrahydrofolate. Disease associated gene polymorphisms:
    ESR: Estrogen receptors; AIF-1: Allograft inflammatory factor-1; PTPN2: Protein
    tyrosine phosphatase non-receptor type 22; HLA: Human leukocyte antigen; TLR4:
    Toll-like receptor 4; CXC: Chemokines; TGFB: tissue growth factor β.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTX1
  - SLC16A7
  - CCL21
  - RFC1
  - SLC19A1
  - AIF1
  - ESR1
  - ESR2
  - HLA-DQB1
  - GNAO1
  - HLA-DQA1
  - HLA-DQB2
  - HLA-DRB1
  - PTPN22
  - TGFB1
  - TLR4
  - CXCL9
  - CXCL10
  - ABCC1
  - ABCC2
  - ABCC3
  - ABCC4
  - ABCA3
  - ABCG2
  - SLC22A11
  - SLC46A1
  - HADHA
  - PLAT
  - IMPA1
  - BRAP
  - APRT
  - MFAP1
  - FPGS
  - GGH
  - AMPD1
  - ADA
  - ADAD1
  - ADAD2
  - ADAR
  - ADARB1
  - ADARB2
  - ADAT1
  - ADAT2
  - ADAT3
  - ATIC
  - CCND1
  - TYMS
  - DHFR
  - SHMT1
  - SHMT2
  - MTRR
  - MS
  - MTHFR
  - CBS
  - slc16a7
  - rfc1
  - esr1
  - akap12b
  - mycbp2
  - aif1l
  - ptpn22
  - tgfb1a
  - abcc1
  - abcc2
  - abcc3
  - abcc4
  - slc46a1
  - fpgs
  - ggh
  - ampd1
  - ada
  - atic
  - ccnd1
  - tyms
  - dhfr
  - mtrr
  - mthfr
  - cbsb
  - Pyrimidine
  - Adenosine
  - Cystathionine
  - Cysteine
  - Folate
  - Homocysteine
  - Inosine
  - Methionine
  - Purine
---
